TARGETING POST-TRANSLATIONAL MODIFICATIONS OF FOXP3: A NEW PARADIGM FOR REGULATORY T CELL-SPECIFIC THERAPY


1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-dihydroisoxazol-5-yl]methyl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione

The fused five- and three six-membered rings of the anthra[1,2-d]imidazoletrione part of the title compound, C27H20N4O4, show two different substituents at the imidazole N atoms, viz.an allyl group and a [3-(pyridin-4-yl)-4,5-dihydroisoxazol-5-yl]methyl group.The fused-ring Stickers system is approximately planar [r.m.s.deviation = 0.232 (2)&

read more


Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria

Abstract Background Chimeric antigen receptor T-cell therapy (CART) prolongs survival for patients with refractory or relapsed lymphoma.Discrepancies among different response criteria for lymphoma under CART were recently shown.Our objective was to evaluate reasons for discordance among different response criteria and their relation to overall surv

read more